1446 (1446) Fair Value & Analysis

Consumer Defensive · Market cap HK$226M

1 1446 1446 · HK

PriceHK$0.3600

Fair ValueHK$0.5083

Upside+41.2%

Quality56/100

Watch 1446 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.3789 – HK$0.6401

Fair value as of: Jul 2, 2026

From 11 valuation models · updated today

Share price −1.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.3194 – HK$0.5273 · fair‑value band HK$0.3789 – HK$0.6401 · the HK$0.3600 price screens below the HK$0.5083 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1446 (1446) currently trades at HK$0.3600, while our model-based Fair Value estimate is HK$0.5083 — implying the stock looks roughly 41.2% undervalued today. We read business quality at 56/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 1446 generated revenue of HK$600M at a net margin of -2.8%. Revenue declined 1.5% year over year. It earns a return on equity of -6.3%. Net debt stands at HK$29.9M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$600M

Revenue growth (YoY) -1.5%

Net margin -2.8%

Return on equity -6.3%

Free cash flow HK$118M FY2025

Operating margin -1.6%

More key figures

EPS (TTM) HK$-0.0200

EPS growth (YoY) +39.8%

Net debt HK$29.9M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1446 reported revenue of HK$600M in FY2025 versus HK$696M in FY2021, a compound −3.6%/yr. Reported net income was −HK$16.7M in FY2025.

Revenue −3.6%/yr

FY21 HK$696M

FY22 HK$687M

FY23 HK$673M

FY24 HK$621M

FY25 HK$600M

Net income

FY21 HK$8.2M

FY22 HK$5.3M

FY23 −HK$34.6M

FY24 −HK$13.7M

FY25 −HK$16.7M

Is 1446 fairly valued? → Check now

Similar stocks

6 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
The Coca-Cola Company CCC3	€67.86	€16.47	-76%
PEP PEP	2,483 MXN	93.50 MXN	-96%
PepsiCo, Inc PEPB34	R$49.70	R$29.18	-41%
Monster Beverage Corporation MNST	$89.55	$40.91	-54%
Nongfu Spring Co 9633	HK$41.72	HK$74.64	+79%
Coca-Cola FEMSA, S.A. C2CA34	R$108.87	R$183.92	+69%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1446 (1446) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.5083 versus a price of HK$0.3600 — about +41% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1446?

Our model-based fair value for 1446 is HK$0.5083 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.3600.

What is the quality score of 1446?

1446 has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1446 (1446)?

1446 reported trailing-twelve-month revenue of about HK$600M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1446?

The net profit margin of 1446 is about -2.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.